The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy

By Bonanno L.   Costa C.   Majem M.   Favaretto A.   Rugge M.   Rosell R.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1130-1132

Oxford University Press

Access to resources Recommend Favorite

Role of BCL2-associated athanogene in resistance to platinum-based chemotherapy in non-small-cell lung cancer

By            

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 984-990

Spandidos Publications

Access to resources Recommend Favorite

Similar survival benefits of a good response and stable disease to platinum-based chemotherapy in non-small cell lung cancer

By            

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1135-1140

Spandidos Publications

Access to resources Recommend Favorite

Role of Non-Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer

By Tummala Mohan K.   Edelman Martin J.  

American Journal of Cancer, Vol. 5, Iss. 4, 2006-01 ,pp. : 245-257

Adis International

Access to resources Recommend Favorite

Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy

By Giaccone Giuseppe   Iacona Renee   Fandi Abderrahim   Janas Mette   Ochs Judith   Herbst Roy   Johnson David  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 3, 2009-03 ,pp. : 467-476

Springer Publishing Company

Access to resources Recommend Favorite